This article uses the option pricing arguments of Merton ( 1974 Merton, RC . 1974. On the pricing of corporate debt: the risk structure of interest rates. Journal of Finance, 29: 449–70. [Crossref], [Web of Science ®] [Google Scholar] ) to demonstrate that even solvent banks will be reluctant to sell volatile, toxic assets at market prices. Banks’ shareholders have insolvency puts that give them limited liability in the event of default. The insolvency puts are more valuable when the banks’ assets are more volatile. Shareholders in banks will require any buyer to pay for the lost volatility as well as the market price of the toxic assets. Thus, taxpayers must be ready to richly overpay if they want banks to voluntarily part with their toxic assets.
7 February 2011 in Risk Management and Insurance Review
The SARS-CoV-2, COVID-19, infection fatality rate (IFR) has been hard to accurately estimate. It is a key parameter for disease modeling and policy decisions. Asymptomatic spread and limited testing have understated infections in hard to predict ways across jurisdictions. We survey serology, antibody, studies of the COVID-19 infection to find official cases are understated by an average of 25-to-1. Further, we analyze the deaths and infections in New York City to estimate an overall IFR for the United States of 0.863 percent.
Old National Bancorp was the first publicly traded bank to buy back its Capital Purchase Program (CPP) warrants. It paid $1.2 million, which is below the low-e
This paper values the Capital Purchase Program (CPP) and Berkshire Hathaway warrants issued by Goldman Sachs in 2008. The paper’s methodology could be of intere